Analytical Data
-
Gene name
EFCAB4A
- Application
-
Alternative Names
CRACR2B. EFCAB4A
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N4Y2
-
Expression Region
1-294aa
-
AA Sequence
MASPGKPGADEAQEEEGELEGGSAGPRAAILEQAEELFLLCDKEAKGFITKHDLQGLQSDLPLTPEQLEAVFESLDQAHTGFLTAREFCLGLGMFVGVASAQGANPCRTPEETFESGGLDVQGTAGSLDEEEEEEERFHTVLEQLGVAPVLGEQRAVRTLWARLQRERPELLGSFEDVLIRASACLEEAARERDGLEQALRRRESEHEREVRALYEETEQLREQSRRPPSQNFARGERRSRLELELQIREQDLERAGLRQRERRGRRLQEHAERESQPATATGAAQGAEYTAAG
-
Molecular Weight
59.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EFCAB4A, or EFCAB4A protein, is a member of the EFCAB family of calcium-binding proteins, which are implicated in various cellular processes, including signal transduction, neuronal function, and muscle contraction. Research has indicated that EFCAB4A plays a significant role in calcium homeostasis and may influence cell fate decisions under various physiological and pathological conditions. Understanding the structure and function of EFCAB4A could provide insights into its role in calcium signaling pathways and its potential involvement in diseases, such as cancer and neurological disorders. The recombinant expression of EFCAB4A facilitates the study of its biochemical properties, interactions with other proteins, and role in cellular signaling networks. Furthermore, by generating and characterizing recombinant EFCAB4A, researchers aim to elucidate its mechanism of action, assess its potential as a biomarker, and explore its therapeutic possibilities. Advances in recombinant protein technologies have enabled the production of EFCAB4A in sufficient quantities for detailed structural and functional analyses, paving the way for innovative studies that may reveal new targets for drug development. As a result, EFCAB4A has garnered attention in the field of molecular biology and medicine, with ongoing research aimed at deciphering its precise contributions to cellular physiology and its implications in human health and disease.
